Where is ORYZON Genomics headquartered?

ORYZON Genomics is located in Cornellá de Llobregat, barcelona.

Who invested in ORYZON Genomics?

ORYZON Genomics has 13 investors including Geekdom Fund And Geekdom Fund.

How much funding has ORYZON Genomics raised to date?

ORYZON Genomics has raised ____.

When was the last funding round for ORYZON Genomics?

ORYZON Genomics closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

oryzon.com

ORYZON Genomics

Oryzon develops and commercializes epigenetic therapies for the treatment of oncology and neurodegenerative diseases.

Business Model:

Revenue: $0

Employees: 11-50

Geographic Data

Address: Calle Sant Ferrán 74

City: Cornellá de Llobregat

State: barcelona

Zip: 08940

Country: ES

Financial Info

Stage:

convertible note

Raised Last:

$21M

Raised Total:

$75M

Social

Facebook

Crunchbase

Metrics

2,228,556Website Global Rank

8,629Website Monthly Traffic

Twitter Followers

Description

Oryzon develops and commercializes epigenetic therapies for the treatment of oncology and neurodegenerative diseases.

Contact Phone:

Contact Email:

IPO Details

ORYZON Genomics went public on 12/15/2015 on the BME Spanish Exchanges

Listed Exchange:
BME Spanish Exchanges

IPO Date:
12/15/2015

Ticker Symbol:
ORY

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
9/2016	Post-IPO Debt		$6M
10/2014	Grant		$1.4M
1/2011	Grant	1	$300k	Alzheimer&s;s Drug Discovery Foundation Alzheimer&s;s Drug Discovery Foundation
4/2017	Grant	1	$300k	Alzheimer&s;s Drug Discovery Foundation Alzheimer&s;s Drug Discovery Foundation Alzheimer&s;s Drug Discovery Foundation Alzheimer&s;s Drug Discovery Foundation
7/2019	IPO		-
6/2022	Grant	1	$2M	European Commission European Commission
5/2016	Post-IPO Debt		$12.1M
12/2016	Grant		$800k
7/2019	Private Placement		$22.3M
9/2021	Grant	1	$1M	Kabuki Syndrome Foundation Kabuki Syndrome Foundation
10/2018	Private Placement		$14.8M
5/2019	Grant	1	$1.5M	Alzheimer&s;s Drug Discovery Foundation Alzheimer&s;s Drug Discovery Foundation Alzheimer&s;s Drug Discovery Foundation Alzheimer&s;s Drug Discovery Foundation
5/2015	Grant	1	$270k	Alzheimer&s;s Drug Discovery Foundation Alzheimer&s;s Drug Discovery Foundation
1/2015	Venture Round	1	-	ICF Capital ICF Capital
12/2022	Grant	1	$423.9k	European Union European Union
10/2015	Series C		$19M
1/2006	Funding Round		-	Grupo Ferrer Internacional Grupo Ferrer Internacional
2/2003	Series A	1	$1.2M	Najeti Capital Najeti Capital
7/2019	Post-IPO Equity		$20M
7/2022	Convertible Note	1	$20.5M	Nice &a; Green SA Nice &a; Green SA
7/2020	Post-IPO Equity		$22.5M
10/2018	Post-IPO Equity		$14.8M
12/2018	Post-IPO Debt		$1.1M
3/2008	Series B		$0	Corsabe Capital Laboratorios Ordesa Corsabe Capital Laboratorios Ordesa
3/2017	Post-IPO Equity		$19.2M
12/2015	Post-IPO Debt		$1.3M
7/2019	IPO		-

Acquisitions

Announced Date	Name	Price
3/2009	Crystax Pharmaceuticals

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details